Mission Bio
/ 400 E Jamie Ct, Suite 100
CA 94080 South San Francisco
US
Mission Bio
Foundation date
2012
Sector
#PharmaSubsector
- #R&D Services - Drug delivery
- #R&D Services - Genomics
- #R&D Services - Proteomics
- #Pharma - Cell therapy
- #Pharma - Drug delivery
- #Pharma - Gene therapy
Mission Bio unlocks the ground truth of cancer through response, relapse, and remission with its Tapestri Platform, powered by single-cell multi-omics. As the first and only to analyze genotype and phenotype simultaneously in single cells, the Tapestri Platform can help unravel the inherent complexity of cancer. Discover how Tapestri enables accurate characterization of your cell and gene therapy candidates for safer and more effective therapeutic strategies. We partner with pharma and biopharma companies across advanced therapy development programs to implement proven single-cell multi-omics capabilities into discovery, translational, and clinical research efforts. Learn more about our Pharma Assay Development services.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
2304 '24
BioTrinity 2024
Event by: OBN -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB
Latest news
More news-
BIO INX Complements Advisory Board with Distinguished Industry Leaders
Thursday April 18th 2024
Read more
-
Innovating today, creating tomorrow: the VIB Bio-Incubator
Thursday April 18th 2024
Read more
-
BioLizard Appoints Matthew Hall as Director of Business Development
Thursday April 18th 2024
Read more
Jobs
More jobs-
-
20/04/24
East Flanders
ERC-funded postdoc position on inter-organelle communication during plant biotic stress responses
Permanent
VIB -
More info?
Ellen Telleir
Communication Coordinator